Copyright
©The Author(s) 2015.
World J Hepatol. Apr 28, 2015; 7(6): 846-858
Published online Apr 28, 2015. doi: 10.4254/wjh.v7.i6.846
Published online Apr 28, 2015. doi: 10.4254/wjh.v7.i6.846
Acquired metabolic disorders |
Diabetes mellitus |
Dyslipidemia |
Kwashiorkor and marasmus |
Obesity |
Starvation |
Cytotoxic and cytostatic drugs |
L-asparaginase |
Azacitidine |
Azaserine |
Bleomycin |
Methotrexate |
Puromycin |
Tetracycline |
Other drugs and toxins |
Amiodarone |
4,4'-diethylaminoethoxyhexestrol |
Dichlorethylene |
Ethionine |
Ethyl bromide |
Estrogens |
Glucocorticoids |
Highly active antiretroviral therapy |
Hydrazine |
Hypoglycin |
Orotate |
Perhexilene maleate |
Safrole |
Tamoxifen |
Metals |
Antimony |
Barium salts |
Chromates |
Phosphorus |
Rare earths of low atomic number |
Thallium compounds |
Uranium compounds |
Inborn errors of metabolism |
Abetalipoproteinemia |
Familial hepatosteatosis |
Galactosemia |
Glycogen storage disease |
Hereditary fructose intolerance |
Homocystinuria |
Systemic carnitine deficiency |
Tyrosinemia |
Weber-Christian syndrome |
Wilson disease |
Surgical procedures |
Biliopancreatic diversion |
Extensive small bowel resection |
Gastric bypass |
Jejunoileal bypass |
Miscellaneous conditions |
Industrial exposure to petrochemicals |
Inflammatory bowel disease |
Partial lipodystrophy |
Jejunal diverticulosis with bacterial overgrowth |
Severe anemia |
Total parenteral nutrition |
- Citation: Abd El-Kader SM, El-Den Ashmawy EMS. Non-alcoholic fatty liver disease: The diagnosis and management. World J Hepatol 2015; 7(6): 846-858
- URL: https://www.wjgnet.com/1948-5182/full/v7/i6/846.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i6.846